Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Clinical Validation Study of the Snouda Metabolic Score (SMS) as a Phenotyping and Protocol-Targeting Instrument in Adults With Type 2 Diabetes Mellitus

NCT07606872 is registered in ClinicalTrials.gov with Salah Snouda as lead sponsor.

NCT NCT07606872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Clinical Validation Study of the Snouda Metabolic Score (SMS) as a Phenotyping and Protocol-Targeting Instrument in Adults With Type 2 Diabetes Mellitus
Lead sponsor
Salah Snouda
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 31, 2026
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome, type 2 diabetes mellitus (t2dm)